GE Healthcare delivers world’s first modular manufacturing solution based on single-use bioprocessing technology in just 18 months (JHL Biotech's Commercial GMP Facility -Wuhan, China). CHALFONT ST. GILES, UK and WUHAN,... read more →
Hsinchu, Taiwan – March 1, 2016 - JHL Biotech, Inc. (Stock Code: 6540.TWO) announced it has entered into a contract manufacturing master service agreement with Affinita Biotech. The agreement covers... read more →
Wuhan, China and Amersham, UK; 25 February 2016: JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1... read more →
HSINCHU, TAIWAN – October 20, 2015— JHL Biotech (TWEM: 6540), an emerging biosimilars company in Taiwan and China, announced today that Max Chan will join the company as Chief Financial Officer... read more →
HSINCHU, TAIWAN – October 2, 2015—JHL Biotech (TWEM: 6540), an emerging biosimilars company incorporated in Cayman Islands and based in Taiwan and China, announced today it has been publicly listed... read more →